$10.50
-0.49 (-4.46%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-44.74%
1Y
-44.74%
YTD
-44.74%
Open$10.98
Previous Close$10.99
Day High$11.49
Day Low$10.30
52W High$19.95
52W Low$8.32
Volume—
Avg Volume505.6K
Market Cap1.36B
P/E Ratio6.00
EPS$9.03
SectorN/A
Technical Indicators
Full analysis →
RSI (14)
28.7
Oversold
Analyst Ratings
Strong Buy
12 analysts
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.90B | 1.45B | 1.25B |
| Net Income | 1.04B | 713.95M | 76.97M |
| Profit Margin | 54.8% | 52.1% | 6.2% |
| EBITDA | -3,011,573,338 | -2,182,299,520 | 127.47M |
| Free Cash Flow | — | — | 81.25M |
| Rev Growth | +31.1% | +31.1% | -0.7% |
| Debt/Equity | 7.75 | 7.75 | 0.17 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $7.12 | +1.86% | — | 4.41B |
| DMII | Drugs Made In America Acquis | $10.09 | -0.10% | 75.0 | 643.37M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.65 | +0.09% | 35.1 | 333.22M |
| CEPF | Cantor Equity Partners-Cl A | $10.36 | +0.19% | 57.6 | 593.22M |
| BCSS | Bain Capital Gss Inv- A | $10.21 | +0.00% | 71.9 | 596.26M |